Plasticell Completes $5.6M Financing Round | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Plasticell today said that it has completed a £3.5 million ($5.6 million) two-part equity financing.

The London-based maker of high-throughput technologies for directed stem cell differentiation, said that it will use the funds to expand its business development and marketing activities as it attempts to grow its customer base. The company has developed the CombiCult technology, which is used to develop stem cell differentiation protocols.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.